{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:14:39Z","timestamp":1793304879737,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Surgical removal of metastasized paraaortic lymph nodes (PALNs) can prolong the survival of certain patients with colorectal cancer (CRC). However, the role of postoperative chemotherapy in such patients remains unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>This multicenter retrospective study examined 97 patients with PALN metastasis from CRC who underwent surgical resection at 36 centers in Japan between 2010 and 2015. On the basis of adjuvant chemotherapy (AC) after the lymphadenectomy, patients were classified into non-AC and AC groups (27 and 70 patients, respectively). After the exclusion of patients receiving irinotecan, the latter group was further categorized into 5-fluorouracil (5-FU) and oxaliplatin (L-OHP) subgroups (14 and 52 patients, respectively) according to the use of L-OHP. Background characteristics and postoperative survival were compared among the groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Marked differences were not seen in background characteristics, except for neoadjuvant treatment, between the non-AC and AC groups. The AC group exhibited better recurrence-free survival (RFS; <jats:italic>p<\/jats:italic> = 0.009) and overall survival (OS; <jats:italic>p<\/jats:italic> = 0.040 by the Wilcoxon test) than the non-AC group. However, RFS and OS of the 5-FU group did not differ from those of the L-OHP group (<jats:italic>p<\/jats:italic> = 0.73 and <jats:italic>p<\/jats:italic> = 0.92 by the Wilcoxon test, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>AC may be associated with improved prognosis of patients after the removal of PALN metastasis from CRC, but L-OHP did not offer additional survival benefits. Prospective studies comparing non-AC with 5-FU- and L-OHP-based AC are needed to confirm these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-024-16537-6","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T16:05:45Z","timestamp":1731945945000},"page":"2282-2291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer\u2014A Multicenter Retrospective Study"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7891-5986","authenticated-orcid":false,"given":"Hiroaki","family":"Nozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sono","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenobu","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Ajioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"16537_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin."},{"key":"16537_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1463-1318.2010.02539.x","volume":"14","author":"AE van der Pool","year":"2012","unstructured":"van der Pool AE, Damhuis RA, Ijzermans JN, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis. 2012;14:56\u201361.","journal-title":"Colorectal Dis."},{"key":"16537_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","volume":"32","author":"LG van der Geest","year":"2015","unstructured":"van der Geest LG, Lam-Boer J, Koopman M, V, et al. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32:457\u201365.","journal-title":"Clin Exp Metastasis."},{"key":"16537_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00384-014-2085-6","volume":"30","author":"MA Elferink","year":"2015","unstructured":"Elferink MA, de Jong KP, Klaase JM, et al. Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands. Int J Colorectal Dis. 2015;30:205\u201312.","journal-title":"Int J Colorectal Dis."},{"key":"16537_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.suronc.2016.09.008","volume":"25","author":"JS Wong","year":"2016","unstructured":"Wong JS, Tan GH, Teo MC. Management of para-aortic lymph node metastasis in colorectal patients: a systemic review. Surg Oncol. 2016;25:411\u20138.","journal-title":"Surg Oncol."},{"key":"16537_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3393\/ac.2019.06.12","volume":"35","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Choi GS. Clinical implications of lymph node metastasis in colorectal cancer: current status and future perspectives. Ann Coloproctol. 2019;35:109\u201317.","journal-title":"Ann Coloproctol."},{"key":"16537_CR7","volume-title":"AJCC Cancer Staging Manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. Eight. New York: Springer; 2017.","edition":"Eight"},{"key":"16537_CR8","doi-asserted-by":"crossref","unstructured":"Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. J Anus Rectum Colon. 2019;3:175-195.","DOI":"10.23922\/jarc.2019-018"},{"key":"16537_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF02616711","volume":"2","author":"MW Stearns Jr","year":"1959","unstructured":"Stearns MW Jr, Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum. 1959;2:169\u201372.","journal-title":"Dis Colon Rectum."},{"key":"16537_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4143\/crt.2017.100","volume":"50","author":"SU Bae","year":"2018","unstructured":"Bae SU, Hur H, Min BS, et al. Which patients with isolated para-aortic lymph node metastasis will truly benefit from extended lymph node dissection for colon cancer? Cancer Res Treat. 2018;50:712\u20139.","journal-title":"Cancer Res Treat."},{"key":"16537_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000491100","volume":"36","author":"K Yamada","year":"2019","unstructured":"Yamada K, Tsukamoto S, Ochiai H, et al. Improving selection for resection of synchronous para-aortic lymph node metastases in colorectal cancer. Dig Surg. 2019;36:369\u201375.","journal-title":"Dig Surg."},{"key":"16537_CR12","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/jso.26829","volume":"125","author":"Y Sun","year":"2022","unstructured":"Sun Y, Yu D, Zhong J, et al. Para-aortic lymph node dissection in left-sided colorectal cancer: risk factors, prognostic impact, and therapeutic value. J Surg Oncol. 2022;125:1251\u20139.","journal-title":"J Surg Oncol."},{"key":"16537_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/jso.27139","volume":"127","author":"C Aylward","year":"2023","unstructured":"Aylward C, Noori J, Tyrrell J, et al. Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: a systematic review. J Surg Oncol. 2023;127:645\u201356.","journal-title":"J Surg Oncol."},{"key":"16537_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00595-023-02739-0","volume":"54","author":"S Emoto","year":"2024","unstructured":"Emoto S, Fukunaga Y, Takamatsu M, et al. Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection. Surg Today. 2024;54:356\u201366.","journal-title":"Surg Today."},{"key":"16537_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jso.21421","volume":"101","author":"PW Choi","year":"2010","unstructured":"Choi PW, Kim HC, Kim AY, et al. Extensive lymphadenectomy in colorectal cancer with isolated para-aortic lymph node metastasis below the level of renal vessels. J Surg Oncol. 2010;101:66\u201371.","journal-title":"J Surg Oncol."},{"key":"16537_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00384-017-2806-8","volume":"32","author":"N Nakai","year":"2017","unstructured":"Nakai N, Yamaguchi T, Kinugasa Y, et al. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer. Int J Colorectal Dis. 2017;32:999\u20131007.","journal-title":"Int J Colorectal Dis."},{"key":"16537_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00384-019-03294-2","volume":"34","author":"K Sahara","year":"2019","unstructured":"Sahara K, Watanabe J, Ishibe A, et al. Long-term outcome and prognostic factors for patients with para-aortic lymph node dissection in left-sided colorectal cancer. Int J Colorectal Dis. 2019;34:1121\u20139.","journal-title":"Int J Colorectal Dis."},{"key":"16537_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12957-020-02118-w","volume":"19","author":"J Lee","year":"2021","unstructured":"Lee J, Park HM, Lee SY, et al. Prognostic significance of enlarged paraaortic lymph nodes detected during left-sided colorectal cancer surgery: a single-center retrospective cohort study. World J Surg Oncol. 2021;19:9.","journal-title":"World J Surg Oncol."},{"key":"16537_CR19","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1111\/codi.15799","volume":"23","author":"SC Lee","year":"2021","unstructured":"Lee SC, Kim HC, Lee WY, et al. Effect of lymphadenectomy in colorectal cancer with isolated synchronous para-aortic lymph node metastasis. Colorectal Dis. 2021;23:2584\u201392.","journal-title":"Colorectal Dis."},{"key":"16537_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12893-022-01631-x","volume":"22","author":"P Zhao","year":"2022","unstructured":"Zhao P, Yang X, Yan Y, et al. Effect of radical lymphadenectomy in colorectal cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis. BMC Surg. 2022;22:181.","journal-title":"BMC Surg."},{"key":"16537_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12957-023-02908-y","volume":"21","author":"RC Wang","year":"2023","unstructured":"Wang RC, Wang JQ, Zhou XY, et al. Survival benefits of para-aortic lymphadenectomy in colorectal cancer with clinically suspected para-aortic lymph node metastasis: a meta-analysis and systematic review. World J Surg Oncol. 2023;21:28.","journal-title":"World J Surg Oncol."},{"key":"16537_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12957-020-02007-2","volume":"18","author":"H Ushigome","year":"2020","unstructured":"Ushigome H, Yasui M, Ohue M, et al. The treatment strategy of R0 resection in colorectal cancer with synchronous para-aortic lymph node metastasis. World J Surg Oncol. 2020;18:229.","journal-title":"World J Surg Oncol."},{"key":"16537_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000003347","author":"S Ito","year":"2024","unstructured":"Ito S, Kinugasa Y, Sato H, et al. Long-term outcome after surgical resection of paraaortic lymph node metastasis of colorectal cancer: a multicenter retrospective study. Dis Colon Rectum. 2024. https:\/\/doi.org\/10.1097\/DCR.0000000000003347.","journal-title":"Dis Colon Rectum."},{"key":"16537_CR24","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1200\/JCO.2008.21.6663","volume":"27","author":"E Van Custem","year":"2009","unstructured":"Van Custem E, Labianca R, Bodoky G, et al. Randomized phase III trial comparing biweekly infusional fluorouracil\/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol. 2009;27:3117\u201325.","journal-title":"J Clin Oncol."},{"key":"16537_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg."},{"key":"16537_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1159\/000439547","volume":"32","author":"A Arimoto","year":"2015","unstructured":"Arimoto A, Uehara K, Kato T, et al. Clinical significance of para-aortic lymph node dissection for advanced or metastatic colorectal cancer in the current era of modern chemotherapy. Dig Surg. 2015;32:439\u201344.","journal-title":"Dig Surg."},{"key":"16537_CR27","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","volume":"26","author":"E Mitry","year":"2008","unstructured":"Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol. 2008;26:4906\u201311.","journal-title":"J Clin Oncol."},{"key":"16537_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162400","volume":"11","author":"K Hasegawa","year":"2016","unstructured":"Hasegawa K, Saiura A, Takayama T, et al. Adjuvant oral uracil-tegafur with leucovorin for colorectal cancer liver metastases: a randomized controlled trial. PLoS One. 2016;11:e0162400.","journal-title":"PLoS One."},{"key":"16537_CR29","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1200\/JCO.21.01032","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shimizu Y, Mizusawa J, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial. J Clin Oncol. 2021;39:3789\u201399.","journal-title":"J Clin Oncol."},{"key":"16537_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","volume":"14","author":"B Nordlinger","year":"2013","unstructured":"Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14:1208\u201315.","journal-title":"Lancet Oncol."},{"key":"16537_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1\u201342.","journal-title":"Int J Clin Oncol."},{"key":"16537_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:10\u201332.","journal-title":"Ann Oncol."},{"key":"16537_CR33","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Colon Cancer Version 4.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf. Accessed 14 July 2024."},{"key":"16537_CR34","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Rectal Cancer Version 3.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf. Accessed 14 July 2024."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-16537-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-16537-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:27:59Z","timestamp":1741195679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-16537-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["16537"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-16537-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}